1. Toxicity of docetaxel, carboplatin, and trastuzumab combination as adjuvant or neo‐adjuvant treatment for Her2 positive breast cancer patients and impact of colony‐stimulating factor prophylaxis. Issue 4 (5th December 2017) Authors: Bayo, Juan; Aviñó, Victoria; Toscano, Fátima; Jiménez, Francisco Journal: Breast journal Issue: Volume 24:Issue 4(2018) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗